Literature DB >> 987820

Determination of halothane-induced sleeping time in the rat: effect of prior administration of centrally active drugs.

M J Turnbull, J W Watkins.   

Abstract

A method is described for the determination of halothane-induced sleeping time in the rat. 2 The sleeping time exhibited a diurnal variation which was due, at least in part, to a change in the sensitivity of the central nervous system (CNS) to the anaesthetic. 3 Tolerance to halothane did not develop in rats repeatedly exposed to the anaesthetic over a period of over 48 hours. 4 Repeated sleeping time determinations have been used to follow changes in the sensitivity of the CNS to the anaesthetic occurring with time. 5 A tolerance to halothane was induced by pretreatment of rats with doses of amylobarbitone, pentobarbitone or meprobamate sufficient to keep animals anaesthetized for approximately 12 hours. This tolerance was followed by a period of halothane-hypersensitivity. 6 Halothane-tolerant animals awakened with higher brain halothane concentrations and were also tolerant to intracerebroventricularly administered pentobarbitone. 7 Halothane-hypertensive rats awakened with lower brain halothane concentrations and were also hypersensitivity to intracerebroventricularly administered pentobarbitone. 8 The possibility that the induction of cross-tolerance to halothane may be indicative of a drug's potential to produce dependence is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 987820      PMCID: PMC1667137          DOI: 10.1111/j.1476-5381.1976.tb07689.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Proceedings: Further observations on the change in sensitivity to halothane induced by acute administration of central nervous system depressant drugs in the rat.

Authors:  M J Turnbull; J W Watkins
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Proceedings: The use of halothane-induced sleeping time as an index of central nervous system excitability.

Authors:  M J Turnbull; J W Watkins
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

Review 3.  Tolerance to, and dependence on, some non-opiate psychotropic drugs.

Authors:  H Kalant; A E LeBlanc; R J Gibbins
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

Review 4.  Circadian rhythms of drug effectiveness and toxicity.

Authors:  M C Ede
Journal:  Clin Pharmacol Ther       Date:  1973 Nov-Dec       Impact factor: 6.875

5.  Daily rhythmic variation in hepatic drug metabolism in the rat and mouse.

Authors:  F M Radzialowski; W F Bousquet
Journal:  J Pharmacol Exp Ther       Date:  1968-09       Impact factor: 4.030

6.  Analysis and differentiation of the mechanism in the development of drug tolerance.

Authors:  R Kato
Journal:  Jpn J Pharmacol       Date:  1967-12

7.  Hexobarbital (enhexymalum NFN) sleeping times and EEG threshold doses as measurements of tolerance to barbiturates in the rat.

Authors:  G Wahlström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1968

8.  Hepatic drug-metabolising enzyme activity and duration of hexobarbitone anaesthesia in barbitone-dependent and withdrawn rats.

Authors:  I H Stevenson; M J Turnbull
Journal:  Biochem Pharmacol       Date:  1968-11       Impact factor: 5.858

9.  Latent hypersensitivity to pentobarbital in the rat.

Authors:  R Aston
Journal:  Proc Soc Exp Biol Med       Date:  1966-02

10.  The sensitivity of the brain to barbiturate during chronic administration and withdrawal of barbitone sodium in the rat.

Authors:  I H Stevenson; M J Turnbull
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

View more
  2 in total

1.  Proceedings of the British Pharmacological Society. 10th-12th September, 1980. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-03       Impact factor: 8.739

2.  Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.

Authors:  D P Clough; R Hatton
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.